Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate -24.10% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Poor long term growth as Operating profit has grown by an annual rate -24.10% of over the last 5 years
3
The company declared negative results in Dec'24 after flat results in Jun'24
4
With ROE of 6.75%, it has a Expensive valuation with a 1.33 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
60.24%
0%
60.24%
6 Months
71.68%
0%
71.68%
1 Year
68.94%
0%
68.94%
2 Years
143.19%
0%
143.19%
3 Years
228.1%
0%
228.1%
4 Years
115.18%
0%
115.18%
5 Years
4.2%
0%
4.2%
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-10.58%
EBIT Growth (5y)
-24.10%
EBIT to Interest (avg)
4.55
Debt to EBITDA (avg)
1.00
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.37
Tax Ratio
16.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.34%
ROE (avg)
10.75%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.33
EV to EBIT
18.02
EV to EBITDA
11.15
EV to Capital Employed
1.31
EV to Sales
3.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.29%
ROE (Latest)
6.75%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
6,955.50
4,354.90
59.72%
Operating Profit (PBDIT) excl Other Income
3,586.90
1,794.10
99.93%
Interest
251.30
327.50
-23.27%
Exceptional Items
-600.30
-727.60
17.50%
Consolidate Net Profit
2,050.70
57.30
3,478.88%
Operating Profit Margin (Excl OI)
453.40%
311.20%
14.22%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 59.72% vs 295.43% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 3,478.88% vs 108.09% in Dec 2022
About YiChang HEC ChangJiang Pharmaceutical Co., Ltd. 
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






